We reiterate BUY while raising our target price by 17%, driven by 4%/3%/2% upward revisions to our 2019F/2020F/2021F NPAT-MI forecasts, a rollover of our valuation to mid-2020, a one-ppt hike to our DCF terminal growth rate and increased target PER for th